Literature DB >> 2932921

Effect of pulmonary and renal circulations on activity of atrial natriuretic factor.

E O Weselcouch, W R Humphrey, J W Aiken.   

Abstract

The effect of passage through the pulmonary and renal circulation on the activity of extracted and synthetic atrial natriuretic factors was determined by monitoring the amount of the vascular relaxing activity surviving passage through the organ. When crude atrial extract was infused through isolated perfused lungs of the guinea pig, approximately 75% of its activity survived. The activity of a 23-amino acid synthetic atrial peptide was decreased 21% on passage through these lungs, but this loss of activity was not significantly different from the crude extract. Analogous experiments in vivo showed that passage through the pulmonary circulation of the dog did not alter the activity of either the crude atrial extract or of synthetic atrial peptide. In contrast to the lack of effect of the pulmonary circulation, approximately 80% of the activity of crude atrial extract and synthetic atrial peptide was removed by the isolated perfused kidney of the rabbit, and in vivo the dog kidney removed approximately 80% of the activity of both these atrial substances. By surviving transit through the pulmonary circulation, these materials exhibit a necessary property of a circulating hormone stored in the right atrium, and the fact that the renal circulation extracts most of these materials is consistent with the kidney being a target organ of this putative hormone.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2932921     DOI: 10.1152/ajpregu.1985.249.5.R595

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Atrial natriuretic peptide receptors along the rat and rabbit nephrons: [125I] alpha-rat atrial natriuretic peptide binding in microdissected glomeruli and tubules.

Authors:  D Butlen; M Mistaoui; F Morel
Journal:  Pflugers Arch       Date:  1987-04       Impact factor: 3.657

2.  Responsiveness of the ANP providing system to volume load in conscious dogs.

Authors:  Y Nishida; A Miyata; H Morita; N Uemura; K Kangawa; H Matsuo; H Hosomi
Journal:  Pflugers Arch       Date:  1988-10       Impact factor: 3.657

3.  Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.

Authors:  H Jin; R H Yang; Y F Chen; R M Jackson; S Oparil
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  Pulmonary and urinary clearance of atrial natriuretic factor in acute congestive heart failure in dogs.

Authors:  M A Perrella; K B Margulies; C M Wei; L L Aarhus; D M Heublein; J C Burnett
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

5.  Secretion of atrial natriuretic peptide from the heart in man.

Authors:  D R Singer; J W Dean; M G Buckley; G A Sagnella; G A MacGregor
Journal:  Br Heart J       Date:  1987-07

6.  Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion.

Authors:  S Adnot; P Andrivet; P E Chabrier; J Piquet; P Plas; P Braquet; F Roudot-Thoraval; C Brun-Buisson
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

7.  Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog.

Authors:  A S Hollister; R J Rodeheffer; F J White; J R Potts; T Imada; T Inagami
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

8.  Hydrolysis of alpha-human atrial natriuretic peptide in vitro by human kidney membranes and purified endopeptidase-24.11. Evidence for a novel cleavage site.

Authors:  Y Vanneste; A Michel; R Dimaline; T Najdovski; M Deschodt-Lanckman
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

9.  Atrial natriuretic hormones--thirty years after the discovery of atrial volume receptors.

Authors:  H J Kramer; B Lichardus
Journal:  Klin Wochenschr       Date:  1986-08-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.